RHYTHM PHARMACEUTICLS ($RYTM) posted quarterly earnings results on Wednesday, February 26th. The company reported earnings of -$0.72 per share, beating estimates of -$0.73 by $0.01. The company also reported revenue of $41,830,000, beating estimates of $39,253,884 by $2,576,116.
You can see Quiver Quantitative's $RYTM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
RHYTHM PHARMACEUTICLS Insider Trading Activity
RHYTHM PHARMACEUTICLS insiders have traded $RYTM stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.
Here’s a breakdown of recent trading of $RYTM stock by insiders over the last 6 months:
- JENNIFER KAYDEN LEE (EVP, Head of North America) has made 0 purchases and 17 sales selling 81,645 shares for an estimated $5,301,044.
- JENNIFER L GOOD has made 0 purchases and 2 sales selling 68,992 shares for an estimated $3,542,503.
- JOSEPH SHULMAN (Chief Technical Officer) has made 0 purchases and 9 sales selling 17,053 shares for an estimated $1,100,851.
- LYNN A. TETRAULT has made 0 purchases and 4 sales selling 20,700 shares for an estimated $1,028,991.
- PAMELA J. CRAMER (Chief Human Resources Officer) has made 0 purchases and 7 sales selling 16,059 shares for an estimated $941,112.
- DAVID P MEEKER (President and CEO) has made 0 purchases and 2 sales selling 14,174 shares for an estimated $820,490.
- HUNTER C SMITH (Chief Financial Officer) has made 0 purchases and 6 sales selling 5,940 shares for an estimated $343,345.
- CHRISTOPHER PAUL GERMAN (Corporate Controller & CAO) sold 635 shares for an estimated $36,334
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RHYTHM PHARMACEUTICLS Hedge Fund Activity
We have seen 104 institutional investors add shares of RHYTHM PHARMACEUTICLS stock to their portfolio, and 92 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC removed 2,067,590 shares (-53.3%) from their portfolio in Q4 2024, for an estimated $115,743,688
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 1,111,043 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $62,196,187
- COMMODORE CAPITAL LP removed 650,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $36,387,000
- PRIMECAP MANAGEMENT CO/CA/ removed 645,721 shares (-8.9%) from their portfolio in Q4 2024, for an estimated $36,147,461
- JANUS HENDERSON GROUP PLC added 621,432 shares (+103.9%) to their portfolio in Q4 2024, for an estimated $34,787,763
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 547,144 shares (-22.6%) from their portfolio in Q4 2024, for an estimated $30,629,121
- NATIONAL BANK OF CANADA /FI/ removed 341,507 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $19,117,561
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
